Sale!

Alunbrig 90mg (brigatinib)30 Tablets

$550.00

Alunbrig 90mg (brigatinib)30 TabletsMore Information on Briganix 90mg 30 Tablets | 98.4 Pharmacy Online

  • Severe, life-threatening, and fatal pulmonary adverse reactions consistent with interstitial lung disease (ILD)/pneumonitis have occurred with

Description

Alunbrig 90mg (brigatinib)30 TabletsMore Information on Briganix 90mg 30 Tablets | 98.4 Pharmacy Online

  • Alunbrig 90mg (brigatinib)30

    , and fatal pulmonary adverse reactions consistent with interstitial lung disease (ILD)/pneumonitis have occurred with brigatinib; monitor for new or worsening respiratory symptoms (eg, dyspnea, cough), particularly during the first week of initiating.

  • Dose-related hypertension reported; control BP prior to treatment; monitor BP afterhttps://bodaxvet.com/ 2 weeks and at least monthly thereafter.
  • Bradycardia (HR <50 bpm) reported; monitor HR and BP; monitor more frequently if concomitant use of drugs known to cause bradycardia cannot be avoided.Alunbrig 90mg (brigatinib)30 Tablets
  • May cause visual disturbances; advise patients to report any visual symptoms.
  • Increased CPK reported; advise patients to report any unexplained muscle pain, tenderness, or weakness; monitor CPK during treatment.
  • Serum pancreatic enzyme elevation reported; monitor lipase and amylase during treatment.
  • May cause new or worsening hyperglycemia; assess fasting serum glucose before initiating drug and periodically thereafter; initiate or optimize antihyperglycemic medications as needed.
  • More Information on Briganix 90mg 30 Tablets | 98.4 Pharmacy Online

    98.4 Pharmacy advice for Briganix 90mg 30 Tablets

    • Severe, life-threatening, and fatal pulmonary adverse reactions consistent with interstitial lung disease (ILD)/pneumonitis have occurred with brigatinib; monitor for new or worsening respiratory symptoms (eg, dyspnea, cough), particularly during the first week of initiating.
    • Dose-related hypertension reported; control BP prior to treatment; monitor BP after 2 weeks and at least monthly thereafter.
    • Bradycardia (HR <50 bpm) reported; monitor HR and BP; monitor more frequently if concomitant use of drugs known to cause bradycardia cannot be avoided.
    • May cause visual disturbances; advise patients to report any visual symptoms.
    • Increased CPK reported; advise patients to report any unexplained muscle pain, tenderness, or weakness; monitor CPK during treatment.
    • Serum pancreatic enzyme elevation reported; monitor lipase and amylase during treatment.
    • May cause new or worsening hyperglycemia; assess fasting serum glucose before initiating drug and periodically thereafter; initiate or optimize
    • 98.4 Pharmacy advice for Briganix 90mg 30 Tablets

      • Severe, life-threatening, and fatal pulmonary adverse reactions consistent with interstitial lung disease (ILD)/pneumonitis have occurred with brigatinib; monitor for new or worsening respiratory symptoms (eg, dyspnea, cough), particularly during the first week of initiating.
      • Dose-related hypertension reported; control BP prior to treatment; monitor BP after 2 weeks and at least monthly thereafter.
      • Bradycardia (HR <50 bpm) reported; monitor HR and BP; monitor more frequently if concomitant use of drugs known to cause bradycardia cannot be avoided.
      • May cause visual disturbances; advise patients to report any visual symptoms.
      • Increased CPK reported; advise patients to report any unexplained muscle pain, tenderness, or weakness; monitor CPK during treatment.
      • Serum pancreatic enzyme elevation reported; monitor lipase and amylase during treatment.
      • May cause new or worsening hyperglycemia; assess fasting serum glucose before initiating drug and periodically thereafter; initiate or optimize

Reviews

There are no reviews yet.

Be the first to review “Alunbrig 90mg (brigatinib)30 Tablets”

Your email address will not be published.